CLBT vs CGNT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CLBT Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cellebrite DI Ltd. Class A Ordinary Shares (CLBT) driven by superior Valuation, Growth & Margin, Options & Structure while CGNT counters with relative strength in Momentum & Technical. Fundamentally, CLBT trades at 16.6x Forward P/E with 11.9% operating margin (+18.2% YoY revenue) versus CGNT at 22.0x Forward P/E and 4.1% operating margin (+12.0% YoY). In options structure, CLBT sits in BREAKDOWN (39th %ile IV; Dealer Gamma Walls on Pro) against CGNT sits in BREAKDOWN (56th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CLBT Revenue | CGNT Revenue | CLBT Op. Margin | CGNT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $170M | $430M | -0.9% | 4.3% | CGNT |
| FY2020 | $190M | $460M | 4.7% | 6.0% | CGNT |
| FY2021 | $250M | $440M | 5.6% | 4.1% | CLBT |
| FY2022 | $270M | $470M | 0.4% | 2.3% | CGNT |
| FY2023 | $330M | $310M | 10.2% | -33.1% | CLBT |
| FY2024 | $400M | $310M | 14.2% | -5.8% | CLBT |
| FY2025 | $480M | $350M | 14.0% | -1.5% | CLBT |
| FY2026 | N/A | $400M | N/A | 3.3% | CGNT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CLBT | CGNT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.9B | $608.5M | Larger Scale | CLBT |
| Trailing P/E Ratio Valuation | 46.1x | 10.3x | Lower Multiple | CGNT |
| Forward P/E Ratio Valuation | 16.6x | 22.0x | Lower Multiple | CLBT |
| Revenue Growth (YoY) Growth | +18.2% | +12.0% | Higher Growth | CLBT |
| Operating Margin (TTM) Profitability | 11.9% | 4.1% | Higher Margin | CLBT |
| Net Profit Margin Profitability | 12.1% | -0.0% | Higher Margin | CLBT |
| Return on Equity (ROE) Capital Efficiency | 12.7% | 2.2% | Higher ROE | CLBT |
| 52-Week Range Position Momentum | 10% ($10โ$19) | 25% ($6โ$12) | Stronger Trend | CGNT |
| Beta / 30D Volatility Risk Regime | 0.58ฮฒ ยท 61% Vol | 1.40ฮฒ ยท 56% Vol | Lower Realized Risk | CGNT |
| Unified Institutional Score Composite Signal | 42.5 / 100 (HOLD) | 49.9 / 100 (HOLD) | Higher Composite | CGNT |